Breast cancer Cancer Malignant neoplasm of the breast
Conditions
Interventions
Women are randomised to:
1. Control arm: no further treatment
2. Treatment arm: relaxation method
Sponsors
Cancer Research UK (CRUK) (UK)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients should: 1. Meet the national HRT study entry criteria 2. Women diagnosed with stage I/II breast cancer with no evidence of recurrence 3. Be postmenopausal (amenorrhoea for >6 months or surgical or radiation ovarian ablation) 4. Be experiencing menopausal hot flushes 5. Able to attend hospital for extra visits 6. Able to complete written records in English
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed